Progress and Challenges toward the Development of Vaccines against Avian Infectious Bronchitis
Open Access
- 1 January 2015
- journal article
- review article
- Published by Hindawi Limited in Journal of Immunology Research
- Vol. 2015, 1-12
- https://doi.org/10.1155/2015/424860
Abstract
Avian infectious bronchitis (IB) is a widely distributed poultry disease that has huge economic impact on poultry industry. The continuous emergence of new IBV genotypes and lack of cross protection among different IBV genotypes have been an important challenge. Although live attenuated IB vaccines remarkably induce potent immune response, the potential risk of reversion to virulence, neutralization by the maternal antibodies, and recombination and mutation events are important concern on their usage. On the other hand, inactivated vaccines induce a weaker immune response and may require multiple dosing and/or the use of adjuvants that probably have potential safety risks and increased economic burdens. Consequently, alternative IB vaccines are widely sought. Recent advances in recombinant DNA technology have resulted in experimental IB vaccines that show promise in antibody and T-cells responses, comparable to live attenuated vaccines. Recombinant DNA vaccines have also been enhanced to target multiple serotypes and their efficacy has been improved using delivery vectors, nanoadjuvants, andin ovovaccination approaches. Although most recombinant IB DNA vaccines are yet to be licensed, it is expected that these types of vaccines may hold sway as future vaccines for inducing a cross protection against multiple IBV serotypes.Keywords
Funding Information
- Ministry of Science, Technology and Innovation
This publication has 114 references indexed in Scilit:
- Transcriptome analysis of chicken kidney tissues following coronavirus avian infectious bronchitis virus infectionBMC Genomics, 2013
- Passive antibody transfer in chickens to model maternal antibody after avian influenza vaccinationVeterinary Immunology and Immunopathology, 2013
- Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike ProteinViruses, 2012
- Modification of the avian coronavirus infectious bronchitis virus for vaccine developmentBioengineered, 2012
- Recombination in Avian Gamma-Coronavirus Infectious Bronchitis VirusViruses, 2011
- A Recombinant Avian Infectious Bronchitis Virus Expressing a Heterologous Spike Gene Belonging to the 4/91 SerotypePLOS ONE, 2011
- Oral and Nasal DNA Vaccines Delivered by Attenuated Salmonella enterica Serovar Typhimurium Induce a Protective Immune Response against Infectious Bronchitis in ChickensClinical and Vaccine Immunology, 2011
- An Interaction between the Nucleocapsid Protein and a Component of the Replicase-Transcriptase Complex Is Crucial for the Infectivity of Coronavirus Genomic RNAJournal of Virology, 2010
- Current Status of Veterinary VaccinesClinical Microbiology Reviews, 2007
- A highly conserved epitope on the spike protein of infectious bronchitis virusArchiv für die gesamte Virusforschung, 1995